Lantheus Holdings, Inc.
NASDAQ: LNTH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mary Anne Heino
- Employees
- 808
- Headquarters
- Bedford, United States
- IPO year
- 2015
- Market cap
- $6.8B
- Website
- https://www.lantheus.com
Loading LNTH…
Loading profile data…Frequently asked questions about LNTH
What does Lantheus Holdings, Inc. (LNTH) do?
Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cance...
Where does LNTH trade?
Lantheus Holdings, Inc. (LNTH) trades on the NASDAQ Global Market.
What sector is LNTH in?
Lantheus Holdings, Inc. (LNTH) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Lantheus Holdings, Inc.?
Mary Anne Heino is the chief executive officer of Lantheus Holdings, Inc. (LNTH).
Where is Lantheus Holdings, Inc. headquartered?
Lantheus Holdings, Inc. is headquartered in United States.
Does LNTH pay a dividend?
Lantheus Holdings, Inc. (LNTH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LNTH go public?
Lantheus Holdings, Inc. (LNTH) completed its initial public offering in 2015.